18 FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec(R))

Author： Stroobants S.   Goeminne J.   Seegers M.   Dimitrijevic S.   Dupont P.   Nuyts J.   Martens M.   van den Borne B.   Cole P.   Sciot R.   Dumez H.   Silberman S.   Mortelmans L.   van Oosterom A.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.39, Iss.14, 2003-09, pp. : 2012-2020

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imatinib mesylate (STI-571 Glivec(R), Gleevec(TM)) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target - Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study

By Verweij J.   van Oosterom A.   Blay J.-Y.   Judson I.   Rodenhuis S.   van der Graaf W.   Radford J.   Le Cesne A.   Hogendoorn P.C.W.   di Paola E.D.   Brown M.   Nielsen O.S.  

European Journal of Cancer, Vol. 39, Iss. 14, 2003-09 ,pp. : 2006-2011

Elsevier

Access to resources Recommend Favorite

Strategies of assessing and quantifying radiation treatment metabolic tumor response using F18 FDG Positron Emission Tomography (PET)

By Fuss Martin  

Acta Oncologica, Vol. 49, Iss. 7, 2010-10 ,pp. : 948-955

Informa Healthcare

Access to resources Recommend Favorite

Determinants of Response to Neoadjuvant Chemotherapy for Esophageal Cancer Using 18F-fluorodeoxiglucose Positron Emission Tomography (18F-FDG-PET)

By Miyata Hiroshi   Yamasaki Makoto   Takahashi Tsuyoshi   Murakami Kohei   Tanaka Koji   Yukinori Kurokawa   Nakajima Kiyokazu   Takiguchi Shuji   Morii Eiichi   Hatazawa Jun   Mori Masaki   Doki Yuichiro  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 575-582

Springer Publishing Company

Access to resources Recommend Favorite

18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT)

By Lassen U.   Daugaard G.   Eigtved A.   Damgaard K.   Friberg L.  

European Journal of Cancer, Vol. 35, Iss. 7, 1999-07 ,pp. : 1076-1082

Elsevier

Access to resources Recommend Favorite

Evaluation of the early response and mechanism of treatment of Parkinson's disease with L-dopa using 18F-fallypride micro-positron emission tomography scanning

By          

Experimental and Therapeutic Medicine, Vol. 11, Iss. 1, 2016-01 ,pp. : 101-109

Spandidos Publications

Access to resources Recommend Favorite